Menin Inhibition in Acute MLL-Rearranged Leukemias: A New Target for Precision Care

Download All
Download slides, review a text module, and read an expert commentary for expert perspectives on the importance and clinical application of emerging therapies targeting menin for patients with MLL-rearranged acute leukemias.
Eytan M. Stein, MD
Eunice S. Wang, MD

Module

Learn about emerging evidence for menin inhibitors in patients with acute leukemias.

Eytan M. Stein, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: October 17, 2022 Expired: No longer available for credit

Review this slideset on menin inhibitors in MLLr/mNPM1 acute leukemias.

Eytan M. Stein, MD Released: October 17, 2022

ClinicalThought

Learn the latest on the emerging role of menin inhibition in MLL-rearranged acute leukemias.

Eunice S. Wang, MD Released: October 26, 2022
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Syndax Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings